Catheterization News and Research

RSS

New BioTAK score accurately identifies Takotsubo syndrome before catheterization

Takotsubo syndrome is an acute heart condition that primarily affects postmenopausal women and is often triggered by severe emotional or physical stress.

31 Aug 2026

New study makes progress in understanding the mechanisms behind severity of HFpEF

Approximately 3 million people in the United States are living with a condition called heart failure with preserved ejection fraction, or HFpEF.

24 Aug 2026

Wearable ultrasound patch tracks critical central venous pressure

The patch probe, with a center frequency of 8.5 MHz, provides excellent spatial resolution and penetration depth.

18 Aug 2026

Explainable AI helps predict dangerous bleeding after severe heart attacks

Researchers at Indiana University School of Medicine have developed and tested a six-point scoring system that can help identify patients at high risk of internal bleeding in damaged heart muscle after a severe heart attack using explainable artificial intelligence (XAI).

9 Aug 2026

A common dietary nutrient feeds a gut pathway linked to atrial fibrillation

Researchers linked higher plasma TMAO to prevalent atrial fibrillation in 5,090 people and found that TMAO or choline supplementation accelerated AF onset, progression, atrial remodeling, and electrical dysfunction in mice. Inhibiting gut microbial TMA production lowered circulating TMAO and delayed AF in mice, identifying a potential therapeutic pathway that now requires human testing.

27 Jul 2026

Review explores diagnosis and management of perioperative anaphylaxis during anesthesia

Perioperative anaphylaxis is a rare, life‑threatening condition during anesthesia. The unique setting – multiple drugs, patient draping, and altered physiology – causes higher mortality than anaphylaxis elsewhere.

29 May 2026

Patient intuition leads to urgent open-heart surgery at NYU Langone Hospital—Brooklyn

Shana Hale, a Brooklyn mother of two and a technology executive, noticed a mild burning sensation in her chest during her daily walks last summer.

20 May 2026

Qureight establishes Scientific Advisory Board focused on pulmonary hypertension

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has established a Scientific Advisory Board (SAB) focused on pulmonary hypertension (PH).

From Qureight 11 May 2026

Email alerts boost valve replacement rates in older patients with aortic stenosis

New data finds older patients with severe aortic stenosis (AS) were more likely to receive aortic valve replacement (AVR) and survive when clinicians received automated email notifications with abnormal heart ultrasound results detecting AS.

25 Apr 2026

Real-world study examines cangrelor dosing for antiplatelet bridging after PCI

A multi-center retrospective cohort study examined how cangrelor has been used in real-world clinical practice around the time of surgery following percutaneous coronary intervention (PCI) and described differences in outcomes seen with different dosing approaches.

24 Apr 2026

Researchers identify ADHD and social traits in preschoolers with heart defects

Congenital heart disease (CHD) which is a problem with how the heart forms before birth -- occurs in approximately 1 % of newborns.

22 Apr 2026

Intensive LDL cholesterol-lowering shows major benefits for heart disease patients

Using cholesterol-lowering medications more intensively to achieve a more aggressive target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular events by one-third among patients with atherosclerotic cardiovascular disease (ASCVD), according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

Catheter-based approach improves prognosis in pulmonary embolism patients

Patients who had low doses of clot-buster drugs delivered directly to the site of a pulmonary embolism (PE) via a catheter using ultrasound to enhance their effect had significantly better outcomes than those who received standard systemic anticoagulants, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

28 Mar 2026

AI-powered wearable ECG system detects myocardial ischemia minutes earlier

Myocardial ischemia, the primary driver of heart attacks, remains the leading cause of death and disability worldwide. Delays in diagnosis directly correlate with increased myocardial necrosis, higher complication rates, and elevated mortality.

10 Mar 2026

Study provides guidance for caring children with febrile urinary tract infection

A new study from the Advocate Aurora Research Institute - which is part of Advocate Health - published Tuesday in Hospital Pediatrics provides guidance for families and physicians caring for infants and young children hospitalized with a febrile urinary tract infection (UTI), one of the most common infections in early childhood.

17 Feb 2026

Cardiac MRI shows promise as a diagnostic tool for coronary heart disease

Cardiac magnetic resonance imaging (MRI) is an appropriate non-invasive procedure for functional diagnostics in patients who, as a result of basic diagnostics, are suspected of having chronic coronary heart disease (CHD) or progression of known CHD: The diagnostic accuracy of cardiac MRI is at least comparable to that of SPECT (single photon emission computed tomography) in the detection of CHD, but does not expose patients to radiation.

27 Jan 2026

Comparative study finds higher rates of adverse events with ticagrelor

One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or type 2 diabetes who had a drug-eluting stent placed in their heart to treat coronary artery blockages did not offer the same level of benefit to prevent stent clotting, heart attacks, and bleeding complications, according to findings presented during a preliminary late-breaking science session during the American Heart Association's Scientific Sessions 2025 in New Orleans on November 10.

10 Nov 2025

Improving diagnosis, treatment and follow-up care for pulmonary embolism

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year - and kills about one in five high-risk patients, according to the American Heart Association 2025 statistical update.

31 Oct 2025

Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced the publication of a peer-reviewed study validating its Vascul8™ model for pulmonary vascular disorders, in the American Journal of Respiratory Cell and Molecular Biology.

27 Oct 2025

VR technology proves better than anti-anxiety meds in coronary angiography

Patients undergoing coronary angiography often experience anxiety both before and during the procedure, often treated by the administration of anti-anxiety medications. A new analysis being presented at the American College of Cardiology (ACC) Middle East 2025 Together with 16th Emirates Cardiac Society Conference found virtual reality (VR) effectively reduced anxiety during the procedure and had more stable vital signs than patients receiving standard care.

3 Oct 2025